ARE WE POSITIVE ABOUT NODE NEGATIVE BREAST-CANCER

被引：2

作者：

DONEGAN, WL

机构：

[1] MED COLL WISCONSIN,MILWAUKEE,WI 53226

[2] SINAI SAMARITAN MED CTR,MILWAUKEE,WI

来源：

JOURNAL OF SURGICAL ONCOLOGY | 1990年 / 43卷 / 04期

关键词：

D O I：

10.1002/jso.2930430402

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：199 / 202

页数：4

共 16 条

[1]

BALCH CM, 1989, NOV AM COLL SURG CLI

[2]

BONADONNA G, 1987, ADJUVANT THERAPY CAN, V5, P211

[3]

CAFFIER H, 1984, ADJUVANT THERAPY CAN, V4, P417

[4]

DECOSSE JJ, 1980, CANCER TREAT REP, V64, P419

[5] BREAST-CANCER THERAPY - EXERCISING ALL OUR OPTIONS [J].

DEVITA, VT .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :527-529

[6]

DONEGAN WL, 1974, ARCH SURG-CHICAGO, V109, P187

[7] A RANDOMIZED CLINICAL-TRIAL EVALUATING SEQUENTIAL METHOTREXATE AND FLUOROURACIL IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR-NEGATIVE TUMORS [J].

FISHER, B ;

REDMOND, C ;

DIMITROV, NV ;

BOWMAN, D ;

LEGAULTPOISSON, S ;

WICKERHAM, DL ;

WOLMARK, N ;

FISHER, ER ;

MARGOLESE, R ;

SUTHERLAND, C ;

GLASS, A ;

FOSTER, R ;

CAPLAN, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :473-478

[8] A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J].

FISHER, B ;

COSTANTINO, J ;

REDMOND, C ;

POISSON, R ;

BOWMAN, D ;

COUTURE, J ;

DIMITROV, NV ;

WOLMARK, N ;

WICKERHAM, DL ;

FISHER, ER ;

MARGOLESE, R ;

ROBIDOUX, A ;

SHIBATA, H ;

TERZ, J ;

PATERSON, AHG ;

FELDMAN, MI ;

FARRAR, W ;

EVANS, J ;

LICKLEY, HL ;

KETNER, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :479-484

[9]

JAKESZ R, 1987, ADJUVANT THERAPY CAN, V5, P223

[10] EFFICACY OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - AN INTERGROUP STUDY [J].

MANSOUR, EG ;

GRAY, R ;

SHATILA, AH ;

OSBORNE, CK ;

TORMEY, DC ;

GILCHRIST, KW ;

COOPER, MR ;

FALKSON, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :485-490

← 1 2 →